Symbol: |
RABL2B
|
Description: |
RAB, member of RAS oncogene family-like 2B [Source:HGNC Symbol;Acc:9800]
|
Location: |
Chr22:51205929-51222091[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:92
Gene |
Compound |
Gen_sig |
Exp_pattern |
RABL2B |
RAPAMYCIN PRODRUG |
0.024 |
Up |
RABL2B |
Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt |
0.003 |
Up |
RABL2B |
Camptothecin hemisuccinate sodium salt |
0.032 |
Down |
RABL2B |
Imidazo[2,1-b]thiazole-5-carboxamide, N-[(4-chlorophenyl)-aminocarbonyl]- |
0.035 |
Up |
RABL2B |
NSC 637128 |
0.043 |
Down |
RABL2B |
Choline, hydroxide, 2-methoxy- 3-[methyl(octadecyl)amino]propyl hydrogen phosphate, inner salt |
0.001 |
Down |
RABL2B |
3-Furancarbothioamide, [[3-(2-butenoxy)-4-methoxyphenyl]- 2-methyl- |
0.018 |
Up |
RABL2B |
NSC 658420 |
0.017 |
Up |
RABL2B |
NSC 660331 |
0.03 |
Up |
RABL2B |
NSC 665686 |
0.045 |
Up |
RABL2B |
Bis[1-(4-methylpiperidino)-4-(2-pyridyl)-2,3-diazapenta 1,3-dien-1-thiolato-N',N3,S]nitrato-bismuth(III) |
0.029 |
Down |
RABL2B |
NSC 667874 |
0.031 |
Down |
RABL2B |
NSC 668324 |
0.011 |
Down |
RABL2B |
NSC 668325 |
0.024 |
Down |
RABL2B |
NSC 668331 |
0.02 |
Down |
Expression pattern: Sensitivity / Resistance
Total:7 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:23
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:5
Gene |
Gen_transcript |
miRNA |
miR_location |
RABL2B |
ENST00000354869 |
hsa-mir-363-3p |
ChrX:133303412-133303433[-] |
RABL2B |
ENST00000354869 |
hsa-mir-491-5p |
Chr9:20716119-20716140[+] |
RABL2B |
ENST00000354869 |
hsa-mir-585 |
Chr5:168690620-168690638[-] |
RABL2B |
ENST00000354869 |
hsa-mir-767-3p |
ChrX:151561919-151561941[-] |
RABL2B |
ENST00000354869 |
hsa-mir-92a-2-5p |
ChrX:133303613-133303634[-] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|